Found 0 matching trials
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
PHASE4Infection with human papillomavirus (HPV) has been clearly established as t...
Location
GSK Investigational Site
Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults
PHASE2Human Papilloma virus (HPV) are viruses that cause a common infection of th...
Location
GSK Investigational Site
Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects
PHASE3Infection with human papillomavirus (HPV) has been clearly established as t...
Location
GSK Investigational Site
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US
PHASE3This phase 3b study is designed to assess the safety of GlaxoSmithKline Bio...
Location
GSK Investigational Site
Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)
PHASE3Infection with human papillomavirus (HPV) has been clearly established as t...
Location
GSK Investigational Site
Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs
PHASE1Human Papillomavirus (HPV) infection has been established as a necessary ca...
Location
GSK Investigational Site
Complementary Testing to Evaluate Immunogenicity of Human Papillomavirus (HPV) Vaccine (580299) in Healthy Female Subjects Aged >/= 26 Years
PHASE3Infection with human papillomavirus (HPV) has been clearly established as t...
Location
GSK Investigational Site
Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A)
PHASE1Infection with human papillomavirus (HPV) has been clearly established as t...
Location
GSK Investigational Site
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Brazil, Taiwan or Thailand
PHASE3This phase 3b study is designed to assess the safety of GlaxoSmithKline Bio...
Location
GSK Investigational Site
Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects
PHASE3Infection with human papillomavirus (HPV) has been clearly established as t...
Location
GSK Investigational Site